WAVE Life Sciences Ltd.
WVE
$6.79
-$0.28-3.96%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 71.80M | 42.73M | 109.23M | 93.95M | 104.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 71.80M | 42.73M | 109.23M | 93.95M | 104.94M |
| Cost of Revenue | 189.60M | 182.78M | 174.61M | 169.93M | 166.86M |
| Gross Profit | -117.80M | -140.05M | -65.38M | -75.99M | -61.92M |
| SG&A Expenses | 79.08M | 75.33M | 70.57M | 67.52M | 63.83M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 268.68M | 258.11M | 245.18M | 237.46M | 230.69M |
| Operating Income | -196.88M | -215.38M | -135.95M | -143.51M | -125.75M |
| Income Before Tax | -183.59M | -204.38M | -121.95M | -129.87M | -112.33M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -183.59 | -204.38 | -121.95 | -129.87 | -112.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -183.59M | -204.38M | -121.95M | -129.87M | -112.33M |
| EBIT | -196.88M | -215.38M | -135.95M | -143.51M | -125.75M |
| EBITDA | -193.47M | -211.94M | -132.45M | -139.92M | -122.02M |
| EPS Basic | -1.05 | -1.21 | -0.74 | -0.88 | -0.83 |
| Normalized Basic EPS | -0.66 | -0.76 | -0.46 | -0.55 | -0.52 |
| EPS Diluted | -1.05 | -1.21 | -0.75 | -0.89 | -0.84 |
| Normalized Diluted EPS | -0.66 | -0.76 | -0.47 | -0.56 | -0.52 |
| Average Basic Shares Outstanding | 712.05M | 674.45M | 655.79M | 620.61M | 586.15M |
| Average Diluted Shares Outstanding | 712.05M | 674.45M | 666.59M | 631.41M | 596.95M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |